Hepatitis is an inflammation of the liver caused by a viral infection, drugs & alcohol, or liver damage. 325 million people globally live with a hepatitis infection. Types B and C are the most dangerous, and together are the most common cause of liver cirrhosis, liver cancer and viral hepatitis-related deaths. Hepatitis typically affects the liver. CBD has shown to be effective against hepatitis C in particular, but not necessarily hepatitis A or B.
Explore A-Z conditions
Cannabis for Hepatitis (Hepatitis A, Hepatitis B and Hepatitis C)
Research Overview
Animal Study
10
Clinical Meta-analysis
3
Clinical Trial
2
Laboratory Study
10
Meta-analysis
39
Total studies
Hepatitis (Hepatitis A, Hepatitis B and Hepatitis C)
64
Positive
37 studies
58%
Inconclusive
14 studies
22%
Negative
13 studies
20%
Do I qualify?
Select your state from the drop down and we’ll let you know.
Relevant studies
The information in our comprehensive A to Z encyclopedia comes from real scientific studies.
Uncover the detailed results of these studies and find out how effective medical marijuana is for dozens of conditions.
- A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo
- Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution Therapy—Data From the German Hepatitis C-Registry (DHC-R)
- A novel synthetic cannabinoid derivative inhibits inflammatory liver damage via negative cytokine regulation.
- Antiviral Potential of Spirulina in Individuals with Human Immunodeficiency Virus or Hepatis C Virus Infections: A Systematic Review and Meta-Analysis
- Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells.